Comparison of 2 synthetically generated recombinant prions

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 44; http://dx.doi.org/10.1126/science.6801762; PMID: 6801762
   PubMed Web of Science ®Google Scholar
• Caughey B, Chesebro B. Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol 1997; 7:56 - 62; http://dx.doi.org/10.1016/S0962-8924(96)10054-4; PMID: 17708907
   PubMed Web of Science ®Google Scholar
• Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW, et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 2000; 97:10168 - 72; http://dx.doi.org/10.1073/pnas.97.18.10168; PMID: 10963679
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 3; http://dx.doi.org/10.1038/35081095; PMID: 11459061
   PubMed Web of Science ®Google Scholar
• Castilla J, Saá P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3 - 21; http://dx.doi.org/10.1016/S0076-6879(06)12001-7; PMID: 17046648
   PubMed Web of Science ®Google Scholar
• Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195 - 206; http://dx.doi.org/10.1016/j.cell.2005.02.011; PMID: 15851027
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 5; http://dx.doi.org/10.1126/science.1183748; PMID: 20110469
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang Z, Wang X, Li J, Zha L, Yuan CG, Weissmann C, Ma J. Genetic informational RNA is not required for recombinant prion infectivity. J Virol 2012; 86:1874 - 6; http://dx.doi.org/10.1128/JVI.06216-11; PMID: 22090130
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Wang F, Wang X, Xu Y, Yang H, Yu G, Yuan C, Ma J. De novo generation of infectious prions with bacterially expressed recombinant prion protein. FASEB J 2013; 27:4768 - 75; http://dx.doi.org/10.1096/fj.13-233965; PMID: 23970796
   PubMed Web of Science ®Google Scholar
• Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083 - 7; http://dx.doi.org/10.1074/jbc.C110.113464; PMID: 20304915
   PubMed Web of Science ®Google Scholar
• Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 2012; 109:8546 - 51; http://dx.doi.org/10.1073/pnas.1204498109; PMID: 22586108
   PubMed Web of Science ®Google Scholar
• Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 2012; 109:E1938 - 46; http://dx.doi.org/10.1073/pnas.1206999109; PMID: 22711839
   PubMed Web of Science ®Google Scholar
• Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 2007; 104:9741 - 6; http://dx.doi.org/10.1073/pnas.0702662104; PMID: 17535913
   PubMed Web of Science ®Google Scholar
• Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:e1000535; http://dx.doi.org/10.1371/journal.ppat.1000535; PMID: 19649330
   PubMed Web of Science ®Google Scholar
• Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, Baskakov IV. Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011; 7:e1001277; http://dx.doi.org/10.1371/journal.ppat.1001277; PMID: 21347353
   PubMed Web of Science ®Google Scholar
• Imamura M, Kato N, Yoshioka M, Okada H, Iwamaru Y, Shimizu Y, Mohri S, Yokoyama T, Murayama Y. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein. J Virol 2011; 85:2582 - 8; http://dx.doi.org/10.1128/JVI.02098-10; PMID: 21228241
   PubMed Web of Science ®Google Scholar
• Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5:e1000421; http://dx.doi.org/10.1371/journal.ppat.1000421; PMID: 19436715
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008; 3:e3872; http://dx.doi.org/10.1371/journal.pone.0003872; PMID: 19060956
   PubMed Web of Science ®Google Scholar
• Baral PK, Wieland B, Swayampakula M, Polymenidou M, Rahman MH, Kav NN, Aguzzi A, James MN. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1. Acta Crystallogr D Biol Crystallogr 2012; 68:1501 - 12; http://dx.doi.org/10.1107/S0907444912037328; PMID: 23090399
   PubMed Web of Science ®Google Scholar
• Féraudet C, Morel N, Simon S, Volland H, Frobert Y, Créminon C, Vilette D, Lehmann S, Grassi J. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 2005; 280:11247 - 58; http://dx.doi.org/10.1074/jbc.M407006200; PMID: 15618225
   PubMed Web of Science ®Google Scholar
• Ma J. The role of cofactors in prion propagation and infectivity. PLoS Pathog 2012; 8:e1002589; http://dx.doi.org/10.1371/journal.ppat.1002589; PMID: 22511864
   PubMed Web of Science ®Google Scholar
• Wang F, Ma J. Role of lipid in forming an infectious prion?. Acta Biochim Biophys Sin (Shanghai) 2013; 45:485 - 93; http://dx.doi.org/10.1093/abbs/gmt038; PMID: 23583976
   PubMed Web of Science ®Google Scholar
• Wang F, Yang F, Hu Y, Wang X, Wang X, Jin C, Ma J. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 2007; 46:7045 - 53; http://dx.doi.org/10.1021/bi700299h; PMID: 17503780
   PubMed Web of Science ®Google Scholar
• Wang F, Yin S, Wang X, Zha L, Sy MS, Ma J. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 2010; 49:8169 - 76; http://dx.doi.org/10.1021/bi101146v; PMID: 20718504
   PubMed Web of Science ®Google Scholar
• Kazlauskaite J, Pinheiro TJ. Aggregation and fibrillization of prions in lipid membranes. Biochem Soc Symp 2005; 211 - 22; PMID: 15649144
   PubMed Web of Science ®Google Scholar
• Kazlauskaite J, Sanghera N, Sylvester I, Vénien-Bryan C, Pinheiro TJ. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 2003; 42:3295 - 304; http://dx.doi.org/10.1021/bi026872q; PMID: 12641461
   PubMed Web of Science ®Google Scholar
• Morillas M, Swietnicki W, Gambetti P, Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999; 274:36859 - 65; http://dx.doi.org/10.1074/jbc.274.52.36859; PMID: 10601237
   PubMed Web of Science ®Google Scholar
• Adler V, Zeiler B, Kryukov V, Kascsak R, Rubenstein R, Grossman A. Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol 2003; 332:47 - 57; http://dx.doi.org/10.1016/S0022-2836(03)00919-7; PMID: 12946346
   PubMed Web of Science ®Google Scholar
• Gomes MP, Millen TA, Ferreira PS, e Silva NL, Vieira TC, Almeida MS, Silva JL, Cordeiro Y. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem 2008; 283:19616 - 25; http://dx.doi.org/10.1074/jbc.M802102200; PMID: 18456654
   PubMed Web of Science ®Google Scholar
• Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869 - 72; http://dx.doi.org/10.1126/science.1183218; PMID: 20044542
   PubMed Web of Science ®Google Scholar
• Timmes AG, Moore RA, Fischer ER, Priola SA. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One 2013; 8:e71081; http://dx.doi.org/10.1371/journal.pone.0071081; PMID: 23936256
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 6; http://dx.doi.org/10.1126/science.1138718; PMID: 17991853
   PubMed Web of Science ®Google Scholar
• Schulz-Schaeffer WJ, Tschöke S, Kranefuss N, Dröse W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156:51 - 6; http://dx.doi.org/10.1016/S0002-9440(10)64705-0; PMID: 10623653
   PubMed Web of Science ®Google Scholar
• Wang X, Bowers SL, Wang F, Pu XA, Nelson RJ, Ma J. Cytoplasmic prion protein induces forebrain neurotoxicity. Biochim Biophys Acta 2009; 1792:555 - 63; http://dx.doi.org/10.1016/j.bbadis.2009.02.014; PMID: 19281844
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Ma J. Conversion of bacterially expressed recombinant prion protein. Methods 2011; 53:208 - 13; http://dx.doi.org/10.1016/j.ymeth.2010.12.013; PMID: 21176786
   PubMed Web of Science ®Google Scholar